EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY 4.0

Myofibre Density Reveals a Critical Threshold Around Age 6 in Steroid‐Naïve Duchenne Muscular Dystrophy: A Retrospective Observational Study

Tetsuhiro Yamakado iD, Yuka Ishikawa iD, Koki Ise iD, Lei Wang iD, Yoshitaka Oda iD, Masumi Tsuda iD, Taichi Kimura iD, Masayoshi Nagao iD, Manabu Ito iD, Shinya Tanaka iD, Zen-Ichi Tanei iD

Neuropathology and Applied Neurobiology · 2026-04 · 52 (2)

DOI: 10.1111/nan.70068 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Neuropathology and Applied Neurobiology, online erschienen am 18.03.2026. Verfasst von Tetsuhiro Yamakado und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cancer Pathology, Faculty of Medicine, Hokkaido University, Sapporo, Hokkaido, Japan. Hauptthemen laut MEDLINE: Muscular Dystrophy, Duchenne, Myofibrils, Muscle, Skeletal. Die Arbeit nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

In Duchenne muscular dystrophy (DMD), robust histological markers for assessing early disease progression remain elusive. We defined myofibre density ( MFD ) as the count of myofibres per square millimetre, which, in our preliminary survey of DMD muscle biopsies, steeply declined with age (Spearman's ρ : −0.85). We aimed to characterise age‐dependent MFD dynamics in early‐stage DMD.

Methods

We retrospectively assessed 46 archival muscle‐biopsy slides (steroid‐naïve; collected > 40 years ago) using semi‐quantitative image analysis with digital restoration. MFD and classical histological variables were quantified. Age– MFD dynamics were modelled with segmented regression and validated using weakly informative Bayesian modelling. The primary measure was the MFD age‐breakpoint. Secondary measures included breakpoint‐detection power, age‐predictive MFD cut‐offs and behaviour of conventional variables across breakpoint‐defined age bands.

Results

After quality and age‐distribution screening, 35 slides (age 1–11 years) were analysed. Segmented regression identified a breakpoint at 6.25 years (95% confidence interval [CI]: 5.08–7.42); after which MFD plateaued at lower levels. Bayesian posterior estimate was 6.37 years (95% credible interval: 5.24–7.66). A 10,000‐run Monte Carlo simulation ( n = 35) showed approximately 80% power to recapture the breakpoint within ±1.25 years. MFD cut‐offs > 596 and < 426 fibres/mm 2 corresponded to 80% and 20% probabilities of age < 6.25 years. Between the early (< 5 years) and late (≥ 7.5 years) age bands defined by the breakpoint–CI limits, myofibre‐size parameters, myofibre area and fat replacement shifted significantly.

Conclusions

MFD , a simple metric, reveals a previously unrecognised phase of rapid myofibre loss lasting up to around age 6 in early‐stage DMD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Muscular Dystrophy, DuchenneMyofibrilsMuscle, SkeletalHumansRetrospective StudiesChild, PreschoolInfantChildMaleDisease Progression

Stichwörter der Autor:innen

Duchenne muscular dystrophyhistologyhistopathologymuscle biopsymyofibre densityneuromuscular disorderspathology

Autor:innen und Institutionen

  • Department of Cancer Pathology, Faculty of Medicine, Hokkaido University, Sapporo, Hokkaido, Japan.
  • Department of Pathology, National Hospital Organization Hokkaido Medical Center, Sapporo, Hokkaido, Japan.
  • Center for Neuromuscular Disease, Child Health and Development, National Hospital Organization Hokkaido Medical Center, Sapporo, Hokkaido, Japan.
  • Institute for Chemical Reaction Design and Discovery (WPI-ICReDD), Hokkaido University, Sapporo, Hokkaido, Japan.
  • Department of Surgical Pathology, Hokkaido University Hospital, Sapporo, Hokkaido, Japan.
  • Department of Pediatrics, National Hospital Organization Hokkaido Medical Center, Sapporo, Hokkaido, Japan.

ORCID-Profile: Tetsuhiro Yamakado, Yuka Ishikawa, Koki Ise, Lei Wang, Yoshitaka Oda, Masumi Tsuda, Taichi Kimura, Masayoshi Nagao, Manabu Ito, Shinya Tanaka, Zen-Ichi Tanei

Zitieren

APA

Yamakado, T., Ishikawa, Y., Ise, K., Wang, L., Oda, Y., Tsuda, M., Kimura, T., Nagao, M., Ito, M., Tanaka, S., & Tanei, Z. I. (2026). Myofibre Density Reveals a Critical Threshold Around Age 6 in Steroid‐Naïve Duchenne Muscular Dystrophy: A Retrospective Observational Study. Neuropathology and Applied Neurobiology, 52(2). https://doi.org/10.1111/nan.70068

Vancouver

Yamakado T, Ishikawa Y, Ise K, Wang L, Oda Y, Tsuda M, et al. Myofibre Density Reveals a Critical Threshold Around Age 6 in Steroid‐Naïve Duchenne Muscular Dystrophy: A Retrospective Observational Study. Neuropathology and Applied Neurobiology. 2026;52(2). doi:10.1111/nan.70068

BibTeX
@article{Yamakado2026,
  author = {Yamakado, Tetsuhiro and Ishikawa, Yuka and Ise, Koki and Wang, Lei and Oda, Yoshitaka and Tsuda, Masumi and Kimura, Taichi and Nagao, Masayoshi and Ito, Manabu and Tanaka, Shinya and Tanei, Zen-Ichi},
  title = {Myofibre Density Reveals a Critical Threshold Around Age 6 in Steroid‐Naïve Duchenne Muscular Dystrophy: A Retrospective Observational Study},
  journal = {Neuropathology and Applied Neurobiology},
  year = {2026},
  volume = {52},
  number = {2},
  doi = {10.1111/nan.70068}
}
Kostenlos starten →